Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+CD25high T cells

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Liu, Qing yang ^a   Yao, Yong ming ^a   Yu, Yan ^a   Dong, Ning ^a   Sheng, Zhi yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRAGALUS POLYSACCHARIDE; PLANT MEDICINAL PRODUCT; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; POLYSACCHARIDE; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTRAGALUS MONGHOLICUS; ASTRAGALUS PLANT; BURN INFECTION; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; GRAM NEGATIVE SEPSIS; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOREGULATION; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; BURN; CHEMISTRY; IMMUNOLOGY; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS;

ANIMALIA; ASTRAGALUS MONGHOLICUS; MUS;

ANIMALS; ANTIGENS, CD4; ASTRAGALUS PLANT; BASE SEQUENCE; BURNS; DNA PRIMERS; FLOW CYTOMETRY; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED BALB C; POLYSACCHARIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; T-LYMPHOCYTES, REGULATORY;

EID: 79958836318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019811     Document Type: Article

References (36)

1. O'Garra A, Vieira PL, Vieira P, Goldfeld AE, (2004) IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378.
2. Mills KH, (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855.
3. Belkaid Y, Rouse BT, (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6: 353-360.
4. Efron P, Moldawer LL, (2003) Sepsis and the dendritic cell. Shock 20: 386-401.
5. Liu QY, Yao YM, Zhang SW, Yan YY, Wu X, (2011) Naturally existing CD11clowCD45RBhigh dendritic cells protect mice from acute severe inflammatory response induced by thermal injury. Immunobiology 216: 47-53.
6. Zheng SG, Meng L, Wang JH, Watanabe M, Barr ML, et al. (2006) Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient. Int Immunol 18: 279-289.
7. Choileain NN, Redmond HP, (2006) Regulatory T-cells and autoimmunity. J Surg Res 130: 124-135.
8. Jonulei H, Schmitt E, (2003) The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171: 6323-6327.
9. Chatila TA, (2005) Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116: 949-959.
10. Purcell EM, Dolan SM, Kriynovich S, Mannick JA, Lederer JA, (2006) Burn injury induces an early activation response by lymph node CD4+T cell. Shock 25: 135-140.
11. Mills KH, (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855.
12. Goleva E, Cardona ID, Ou LS, Leung DY, (2005) Factors that regulate naturally occurring T regulatory cell-mediated suppression. J Allergy Clin Immunol 116: 1094-1100.
13. Bacchetta R, Gregori S, Roncarolo MG, (2005) CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 4: 491-496.
14. Thompson C, Powrie F, (2004) Regulatory T cells. Curr Opin Pharmacol 4: 408-414.
15. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, (2004) Crucial role of FoxP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16: 1643-1656.
16. Coffer PJ, Burgering BM, (2004) Forkhead box transcription factors and their role in the immune system. Nat Rev Immunol 4: 889-899.
17. Sakaguchi S, (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
18. Kim SW, Fan MZ, Applegate TJ, (2008) Nonruminant nutrition symposium on natural phytobiotics for health of young animals and poultry: mechanisms and application. J Anim Sci 86: E138-E139.
19. Chen W, Li YM, Yu MH, (2009) Astragalus polysaccharides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation. J Diabets Complicat 24: 199-208.
20. Ma XQ, Shi Q, Duan JA, Dong T, Tsim K, (2002) Chemical analysis of radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agr Food Chem 50: 4861-4866.
21. Shao BM, Xu W, Dai H, Tu PF, Li ZJ, et al. (2004) A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophy Res Co 320: 1103-1111.
22. Tin M, Cho CH, Chan K, James AE, Ko J, (2007) Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis 28: 1347-1355.
23. Kuo YH, Tsai WJ, Loke SH, Wu TS, Chiou WF, (2009) Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J Ethnopharmacol 122: 28-34.
24. Cho WC, Leung KN, (2007) In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 113: 132-141.
25. Tu WW, Yang XQ, Wang LJ, Zhang YW, Shen J, (1995) Experimental research on Astragalus membranaceus treating for IgG subclass deficiency II. Observation on the regulation of cytokine activities in vitro. Chin J Immunol 11: 34-37.
26. Liu QY, Yao YM, Zhang SW, Sheng ZY, (2010) Astragalus polysaccharides regulate T cell-mediated immunity via CD11chighCD45RBlow dendritic cells in vitro. J Ethnopharmacol doi:10.1016/j.jep.2010.06.041.
27. Patenaude J, D'Elia M, Hamelin C, Garrel D, Bernier J, (2005) Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells. J Leukoc Biol 77: 141-150.
28. Murphy TJ, Ni Choileain N, Zang Y, Mannick JA, Lederer JA, (2005) CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 174: 2957-2963.
29. Belkaid Y, Rouse BT, (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6: 353-360.
30. Miyara M, Sakaguchi S, (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13: 108-116.
31. Belkaid Y, Rouse BT, (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6: 353-360.
32. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
33. Sunden-Cullberg J, Norrby-Teglund A, Treutiger CJ, (2006) The role of high mobility group box-1 protein in severe sepsis. Curr Opin Infect Dis 19: 231-236.
34. Das G, Sheridan S, Janeway CA, (2001) The source of early IFN-gamma that plays a role in Th1 priming. J Immunol 167: 2004-2010.
35. Arazi A, Sharabi A, Zinger H, Mozes E, Neumann AU, (2009) In Vivo Dynamical Interactions between CD4 Tregs, CD8 Tregs and CD4+CD25- Cells in Mice. PLoS ONE 4 (12): e8447.
36. Wisnoski N, Chung CS, Chen Y, Huang X, Ayala A, (2007) The contribution of CD4+CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27: 251-257.